Presentation is loading. Please wait.

Presentation is loading. Please wait.

Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration.

Published byMaija Kyllönen Modified over 5 years ago

Similar presentations

Presentation on theme: "Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration."— Presentation transcript:

1 Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses  Nicholas G. Smedira, MD, Eugene H. Blackstone, MD, Eric E. Roselli, MD, Colleen C. Laffey, RN, Delos M. Cosgrove, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 131, Issue 3, Pages e4 (March 2006) DOI: /j.jtcvs Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Freedom from explantation for structural valve deterioration (SVD) of stented bovine pericardial bioprostheses (open circles) and allografts (closed circles) used for aortic valve replacement. Vertical bars are asymmetric 68% confidence limits equivalent to 1 SE. A, Patients 50 years of age and younger at valve replacement. There were 406 patients with allografts experiencing 19 events (186 and 32 at risk at 5 and 10 years) and 51 patients with pericardial bioprostheses experiencing 23 events (43 and 29 at risk at 5 and 10 years; P = .5). B, Patients >50 to 60 years of age at valve replacement. Three patients whose indication for pericardial prosthesis explantation could not be determined were excluded. There were 203 patients with allografts experiencing 7 events (103 and 20 at risk at 5 and 10 years) and 84 patients with pericardial bioprostheses experiencing 24 events (67 and 46 at risk at 5 and 10 years; P = .7). C, Patients 60 years and older at valve replacement. There were 135 patients with allografts experiencing 1 event (70 and 8 at risk at 5 and 10 years) and 340 patients with pericardial bioprostheses experiencing 23 events (254 and 131 at risk at 5 and 10 years; P = .9). The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Freedom from explantation for structural valve deterioration of stented bovine pericardial bioprostheses (open circles) and allografts (closed circles) used for aortic valve replacement in propensity-matched patients. Vertical bars are asymmetric 68% confidence limits equivalent to 1 SE. The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

4 Figure E1 Explantation for structural valve deterioration (SVD) of stented bovine pericardial bioprostheses and allografts used for aortic valve replacement. A, Freedom from explantation for SVD. Symbols represent each event, positioned according to the Kaplan-Meier method; open circles represent the pericardial group, and open squares, the allograft group. Vertical bars are asymmetric confidence limits equivalent to 1 SE. Numbers in parentheses are the number of traced patients. Solid lines are parametric estimates enclosed within dashed confidence limits equivalent to 1 SE. B, Instantaneous risk of explantation for SVD (hazard function). The model formed for allografts consisted of a constant hazard phase (0.35% per year) and a late rising hazard phase of Weibull shape (hazard = 1.6 × 10−6t4.6, where t = time in years since implantation); that for pericardial prostheses consisted of a Weibul late phase (hazard = 1.4 × 10×5t3.7). The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

5 Figure E2 Freedom from explantation for structural valve deterioration (SVD) according to age at implantation. Equations from separate hazard functions for each type of prosthesis (Table 3) were solved for 4 specific ages at index operation. Solid lines are parametric estimates enclosed within dashed confidence limits equivalent to 1 SE. A, Age 40 years. B, Age 50 years. C, Age 60 years. The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

6 Figure E3 Probability of explantation for structural valve deterioration (SVD) by 12 years as a function of age at implantation. Equations from separate hazard functions for each type of valve (Table 3) were solved at 12 years as a continuous function of age at index operation. Solid lines are point estimates. Wide dashed lines are confidence limits for allograft estimates, and fine dashed lines are those for pericardial prostheses. The Journal of Thoracic and Cardiovascular Surgery  , e4DOI: ( /j.jtcvs ) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration."

Similar presentations

Tomislav Mihaljevic, MD, Edward R

Tomislav Mihaljevic, MD, Edward R
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: The role of intrathecal papaverine 

Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: The role of intrathecal papaverine 
The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,
Characterization and Importance of Air Leak After Lobectomy

Characterization and Importance of Air Leak After Lobectomy
Scott Goldman, MD, Anson Cheung, MD, Joseph E. Bavaria, MD, Michael R

Scott Goldman, MD, Anson Cheung, MD, Joseph E. Bavaria, MD, Michael R
Prognosis of patients removed from a transplant waiting list for medical improvement: Implications for organ allocation and transplantation for status.

Prognosis of patients removed from a transplant waiting list for medical improvement: Implications for organ allocation and transplantation for status.
Advising complex patients who require complex heart operations

Advising complex patients who require complex heart operations
Should lung transplantation be performed for patients on mechanical respiratory support? The US experience  David P. Mason, MD, Lucy Thuita, MS, Edward.

Should lung transplantation be performed for patients on mechanical respiratory support? The US experience  David P. Mason, MD, Lucy Thuita, MS, Edward.
Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H

Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H
Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation?  Tara Karamlou, MD, Eugene.

Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation?  Tara Karamlou, MD, Eugene.
Effect of changes in postoperative spirometry on survival after lung transplantation  David P. Mason, MD, Jeevanantham Rajeswaran, MSc, Liang Li, PhD,

Effect of changes in postoperative spirometry on survival after lung transplantation  David P. Mason, MD, Jeevanantham Rajeswaran, MSc, Liang Li, PhD,
Endovascular versus open elephant trunk completion for extensive aortic disease  Eric E. Roselli, MD, Sreekumar Subramanian, MD, Zhiyuan Sun, BS, Jahanzaib.

Endovascular versus open elephant trunk completion for extensive aortic disease  Eric E. Roselli, MD, Sreekumar Subramanian, MD, Zhiyuan Sun, BS, Jahanzaib.
Mitral Valve Surgery in the Adult Marfan Syndrome Patient

Mitral Valve Surgery in the Adult Marfan Syndrome Patient
Surgical treatment of pseudoaneurysm of the thoracic aorta

Surgical treatment of pseudoaneurysm of the thoracic aorta
Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome  Soren Schenk, MD, Patrick M. McCarthy,

Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome  Soren Schenk, MD, Patrick M. McCarthy,
Reoperation After Mitral Valve Repair for Degenerative Disease

Reoperation After Mitral Valve Repair for Degenerative Disease
The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,
Sina Ercan, MD, Thomas W. Rice, MD, Sudish C. Murthy, MD, PhD, Lisa A

Sina Ercan, MD, Thomas W. Rice, MD, Sudish C. Murthy, MD, PhD, Lisa A
Clostridium difficile infection after cardiac surgery: Prevalence, morbidity, mortality, and resource utilization  Suresh Keshavamurthy, MBBS, MS, Colleen.

Clostridium difficile infection after cardiac surgery: Prevalence, morbidity, mortality, and resource utilization  Suresh Keshavamurthy, MBBS, MS, Colleen.

Similar presentations

Ads by Google